{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T10:28:45Z","timestamp":1793442525672,"version":"4.5.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100008463","name":"Universitas Airlangga","doi-asserted-by":"publisher","award":["No. 410\/UN3. LPPM\/PT.01.03\/2024"],"award-info":[{"award-number":["No. 410\/UN3. LPPM\/PT.01.03\/2024"]}],"id":[{"id":"10.13039\/501100008463","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008463","name":"Universitas Airlangga","doi-asserted-by":"publisher","award":["No. 410\/UN3. LPPM\/PT.01.03\/2024"],"award-info":[{"award-number":["No. 410\/UN3. LPPM\/PT.01.03\/2024"]}],"id":[{"id":"10.13039\/501100008463","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008463","name":"Universitas Airlangga","doi-asserted-by":"publisher","award":["No. 410\/UN3. LPPM\/PT.01.03\/2024"],"award-info":[{"award-number":["No. 410\/UN3. LPPM\/PT.01.03\/2024"]}],"id":[{"id":"10.13039\/501100008463","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-04571-7","type":"journal-article","created":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T16:46:29Z","timestamp":1748796389000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Oral curative therapeutic study of N-nitrosodiethylamine-induced mouse liver damage of chitosan-coated ursolic acid niosomes"],"prefix":"10.1038","volume":"15","author":[{"given":"Andang","family":"Miatmoko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Aziz","family":"Jauhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia Anneke","family":"Faradisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devy Maulidya","family":"Cahyani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berlian Sarasitha","family":"Hariawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joni","family":"Susanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thaigarajan","family":"Parumasivam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esti","family":"Hendradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Retno","family":"Sari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,1]]},"reference":[{"key":"4571_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","volume":"70","author":"SK Asrani","year":"2019","unstructured":"Asrani, S. K., Devarbhavi, H., Eaton, J. & Kamath, P. S. Burden of liver diseases in the world. J. Hepatol. 70, 151\u2013171 (2019).","journal-title":"J. Hepatol."},{"key":"4571_CR2","first-page":"1385","volume":"8","author":"S Krishnan","year":"2019","unstructured":"Krishnan, S. Liver diseases-an overview. World J. Pharm. Pharm. Sci. 8, 1385\u20131395 (2019).","journal-title":"World J. Pharm. Pharm. Sci."},{"key":"4571_CR3","unstructured":"World Health Organization. Updated WHO projections of mortality and causes of death 2016\u20132060  1\u201326  (2016)."},{"key":"4571_CR4","unstructured":"Sharma, A. & Nagalli, S. Chronic liver disease pathophysiology histopathology. StatPearls 2023, 1\u20139 (2023)."},{"key":"4571_CR5","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2174\/1566524033479528","volume":"3","author":"H Higuchi","year":"2005","unstructured":"Higuchi, H. & Gores, G. J. Mechanisms of liver injury: an overview. Curr. Mol. Med. 3, 483\u2013490 (2005).","journal-title":"Curr. Mol. Med."},{"key":"4571_CR6","doi-asserted-by":"publisher","first-page":"104735","DOI":"10.1016\/j.fitote.2020.104735","volume":"147","author":"Q Sun","year":"2020","unstructured":"Sun, Q. et al. Ursolic acid: a systematic review of its pharmacology, toxicity and rethink on its pharmacokinetics based on PK-PD model. Fitoterapia 147, 104735 (2020).","journal-title":"Fitoterapia"},{"key":"4571_CR7","doi-asserted-by":"crossref","unstructured":"Shaikh, N. et al. A review on ursolic acid: a naturally obtained pentacyclic triterpene. Int. J. Pharm. Pharm. Sci. 13, 1\u20135 (2021).","DOI":"10.22159\/ijpps.2021v13i6.41106"},{"key":"4571_CR8","doi-asserted-by":"crossref","unstructured":"Wang, L. et al. Nanoformulations of ursolic acid: a modern natural anticancer molecule. Front. Pharmacol. 12, 145 (2021).","DOI":"10.3389\/fphar.2021.706121"},{"key":"4571_CR9","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.foodres.2017.10.028","volume":"103","author":"L L\u00f3pez-hortas","year":"2018","unstructured":"L\u00f3pez-hortas, L., P\u00e9rez-larr\u00e1n, P., Gonz\u00e1lez-mu\u00f1oz, M. J., Falqu\u00e9, E. & Dom\u00ednguez, H. Recent developments on the extraction and application of ursolic acid. A review. Food Res. Int. 103, 130\u2013149 (2018).","journal-title":"Food Res. Int."},{"issue":"3","key":"4571_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.4196\/kjpp.2018.22.3.235","volume":"22","author":"D Seo Y","year":"2018","unstructured":"Seo Y, D. et al. Ursolic acid in health and disease. Korean J. Physiol. Pharmacol. 22 (3), 235\u2013248 (2018).","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"4571_CR11","doi-asserted-by":"crossref","unstructured":"Ali, S. A., Ibrahim, N. A., Mohammed, M. M. D., El-hawary, S. & Refaat, E. A. The potential chemo preventive effect of ursolic acid isolated from Paulownia tomentosa, against N-diethylnitrosamine : initiated and promoted hepatocarcinogenesis. Heliyon 5, 5 (2019).","DOI":"10.1016\/j.heliyon.2019.e01769"},{"key":"4571_CR12","doi-asserted-by":"crossref","unstructured":"Miatmoko, A., Mianing, E. A., Sari, R. & Hendradi, E. Nanoparticles use for delivering ursolic acid in cancar therapy: a scoping review  (2021).","DOI":"10.3389\/fphar.2021.787226"},{"key":"4571_CR13","doi-asserted-by":"publisher","first-page":"6643","DOI":"10.1007\/s00253-016-7360-8","volume":"100","author":"H Jin","year":"2016","unstructured":"Jin, H. et al. Ursolic acid-loaded Chitosan nanoparticles induce potent anti-angiogenesis in tumor. Appl. Microbiol. Biotechnol. 100, 6643\u20136652 (2016).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"4571_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21165920","volume":"21","author":"V Khwaza","year":"2020","unstructured":"Khwaza, V., Oyedeji, O. O. & Aderibigbe, B. A. Ursolic acid-based derivatives as potential anti-cancer agents: an update. Int. J. Mol. Sci. 21, 1\u201327 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"4571_CR15","doi-asserted-by":"crossref","unstructured":"Seleci, D. A., Seleci, M., Walter, J. G., Stahl, F. & Scheper, T. Niosomes as nanoparticular drug carriers: Fundamentals and recent applications. J. Nanomater.  (2016).","DOI":"10.1155\/2016\/7372306"},{"key":"4571_CR16","doi-asserted-by":"publisher","first-page":"796","DOI":"10.3109\/02652048.2013.788088","volume":"30","author":"Z Sezgin-bayindir","year":"2013","unstructured":"Sezgin-bayindir, Z., Onay-besikci, A., Vural, N. & Yuksel, N. Niosomes encapsulating Paclitaxel for oral bioavailability enhancement: preparation, characterization, pharmacokinetics and biodistribution. J. Microencapsul. 30, 796\u2013804 (2013).","journal-title":"J. Microencapsul."},{"key":"4571_CR17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.addr.2020.06.017","volume":"154\u2013155","author":"R B\u00f6ttger","year":"2020","unstructured":"B\u00f6ttger, R. et al. Lipid-based nanoparticle technologies for liver targeting. Adv. Drug Deliv Rev. 154\u2013155, 79\u2013101 (2020).","journal-title":"Adv. Drug Deliv Rev."},{"key":"4571_CR18","doi-asserted-by":"crossref","unstructured":"Li, J. et al. Chitosan-based nanomaterials for drug delivery. Molecules  23, 2661 (2018).","DOI":"10.3390\/molecules23102661"},{"key":"4571_CR19","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.msec.2014.10.070","volume":"46","author":"S Moghassemi","year":"2015","unstructured":"Moghassemi, S., Parnian, E., Hakamivala, A. & Darzianiazizi, M. Uptake and transport of insulin across intestinal membrane model using trimethyl Chitosan coated insulin niosomes. Mater. Sci. Eng. C. 46, 333\u2013340 (2015).","journal-title":"Mater. Sci. Eng. C"},{"key":"4571_CR20","doi-asserted-by":"publisher","first-page":"660","DOI":"10.4103\/1735-5362.327512","volume":"16","author":"A Miatmoko","year":"2021","unstructured":"Miatmoko, A. et al. Characterization and distribution of niosomes containing ursolic acid coated with Chitosan layer. Res. Pharm. Sci. 16, 660\u2013673 (2021).","journal-title":"Res. Pharm. Sci."},{"key":"4571_CR21","doi-asserted-by":"publisher","DOI":"10.5772\/17020","author":"ES Alvarenga","year":"2011","unstructured":"Alvarenga, E. S. de. Characterization and properties of Chitosan. Biotechnol. Biopolym. https:\/\/doi.org\/10.5772\/17020 (2011).","journal-title":"Biotechnol. Biopolym"},{"key":"4571_CR22","doi-asserted-by":"crossref","unstructured":"Karim, K. et al. A future of targeted drug delivery systems. J. Adv. Pharm. Technol. Res. 1, 374\u2013380 (2010).","DOI":"10.4103\/0110-5558.76435"},{"key":"4571_CR23","doi-asserted-by":"publisher","unstructured":"Khalifa, A. M. & Rasool, B. K. A. Optimized mucoadhesive coated niosomes as a sustained oral delivery system of famotidine  (2017). https:\/\/doi.org\/10.1208\/s12249-017-0780-7.","DOI":"10.1208\/s12249-017-0780-7"},{"key":"4571_CR24","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.msec.2016.11.014","volume":"71","author":"M Wang","year":"2017","unstructured":"Wang, M. et al. Ursolic acid liposomes with Chitosan modification: promising antitumor drug delivery and efficacy. Mater. Sci. Eng. C. 71, 1231\u20131240 (2017).","journal-title":"Mater. Sci. Eng. C"},{"key":"4571_CR25","doi-asserted-by":"publisher","unstructured":"Mohammed, M. A., Syeda, J. T. M., Wasan, K. M. & Wasan, E. K. An overview of Chitosan nanoparticles and its application in Non-Parenteral drug delivery  (2017). https:\/\/doi.org\/10.3390\/pharmaceutics9040053.","DOI":"10.3390\/pharmaceutics9040053"},{"key":"4571_CR26","doi-asserted-by":"crossref","unstructured":"Moraru, C., Mincea, M., Menghiu, G. & Ostafe, V. Understanding the factors influencing Chitosan-Based Nanoparticles-Protein Corona interaction and drug delivery applications. Molecules 25, 412 (2020).","DOI":"10.3390\/molecules25204758"},{"key":"4571_CR27","doi-asserted-by":"crossref","unstructured":"Miatmoko, A. et al. The effect of Chitosan addition on cellular uptake and cytotoxicity of ursolic acid niosomes. An Acad. Bras. Cienc 93, 456 (2021).","DOI":"10.1590\/0001-3765202120201850"},{"key":"4571_CR28","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1515\/jbcpp-2020-0475","volume":"32","author":"DM Cahyani","year":"2021","unstructured":"Cahyani, D. M., Miatmoko, A., Hariawan, B. S. & Purwantari, K. E.  N-nitrosodiethylamine induces in flammation of liver in mice. J. Basic. Clin. Physiol. Pharmacol. 32, 505\u2013510 (2021).","journal-title":"J. Basic. Clin. Physiol. Pharmacol."},{"key":"4571_CR29","unstructured":"Priyambudi, P. Y. Pengaruh pelapisan kitosan terhadap kadar niosom asam ursolat dalam plasma dan liver yang diberikan peroral pada mencit yang diinduksi N -nitrosodietilamin. Unpublished Report (2021)."},{"key":"4571_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-26085-2","volume":"12","author":"A Miatmoko","year":"2022","unstructured":"Miatmoko, A. et al. The effectiveness of ursolic acid niosomes with Chitosan coating for prevention of liver damage in mice induced by n-nitrosodiethylamine. Sci. Rep. 12, 1\u201313 (2022).","journal-title":"Sci. Rep."},{"key":"4571_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1515\/intox-2015-0001","volume":"8","author":"D Mukherjee","year":"2015","unstructured":"Mukherjee, D. & Ahmad, R. Dose-dependent effect of N\u2032-Nitrosodiethylamine on hepatic architecture, RBC rheology and polypeptide repertoire in Wistar rats. Interdiscip Toxicol. 8, 1\u20137 (2015).","journal-title":"Interdiscip Toxicol."},{"key":"4571_CR32","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0378-5173(82)90142-9","volume":"13","author":"I Zimmermann","year":"1983","unstructured":"Zimmermann, I. Determination of pKa values from solubility data. Int. J. Pharm. 13, 57\u201365 (1983).","journal-title":"Int. J. Pharm."},{"key":"4571_CR33","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/BF03245842","volume":"6","author":"H Du","year":"2009","unstructured":"Du, H. & Chen, X. Q. A comparative study of the separation of oleanolic acid and ursolic acid in Prunella vulgaris by high-performance liquid chromatography and cyclodextrin-modified micellar electrokinetic chromatography. J. Iran. Chem. Soc. 6, 334\u2013340 (2009).","journal-title":"J. Iran. Chem. Soc."},{"key":"4571_CR34","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1039\/C6CE02136K","volume":"19","author":"RQ Chen","year":"2017","unstructured":"Chen, R. Q. et al. An investigation of the effects of varying pH on protein crystallization screening. CrystEngComm 19, 860\u2013867 (2017).","journal-title":"CrystEngComm"},{"key":"4571_CR35","doi-asserted-by":"publisher","unstructured":"Thakur, P., Sonawane, S. S., Sonawane, S. H. & Bhanvase, B. A. Nanofluids-based delivery system, encapsulation of nanoparticles for stability to make stable nanofluids. Encapsul Active Mol. Their Deliv. Syst. (2020). https:\/\/doi.org\/10.1016\/b978-0-12-819363-1.00009-0.","DOI":"10.1016\/b978-0-12-819363-1.00009-0"},{"key":"4571_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pr9030445","volume":"9","author":"C Sebaaly","year":"2021","unstructured":"Sebaaly, C., Trifan, A., Sieniawska, E. & Greige-Gerges, H. Chitosan-coating effect on the characteristics of liposomes: A focus on bioactive compounds and essential oils: a review. Processes 9, 1\u201347 (2021).","journal-title":"Processes"},{"key":"4571_CR37","doi-asserted-by":"publisher","first-page":"5029","DOI":"10.1016\/j.electacta.2006.03.062","volume":"51","author":"S Garcia-Manyes","year":"2006","unstructured":"Garcia-Manyes, S., Oncins, G. & Sanz, F. Effect of pH and ionic strength on phospholipid nanomechanics and on deposition process onto hydrophilic surfaces measured by AFM. Electrochim. Acta. 51, 5029\u20135036 (2006).","journal-title":"Electrochim. Acta"},{"key":"4571_CR38","unstructured":"Feldman, M., Friedman, L. S. & Brandt, L. J. Sleisenger and Fordtran\u2019s Gastrointestinal and Liver Disease, vol. 10  (Elsevier Saunders, 2016)."},{"key":"4571_CR39","doi-asserted-by":"publisher","DOI":"10.12968\/bjha.2021.15.4.174","author":"AL Mescher","year":"2013","unstructured":"Mescher, A. L. Junqueira\u2019s basic histology text & atlas. McGraw-Hill Educ. https:\/\/doi.org\/10.12968\/bjha.2021.15.4.174 (2013).","journal-title":"McGraw-Hill Educ."},{"key":"4571_CR40","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1590\/S0004-28032012000300005","volume":"49","author":"LR Anast\u00e1cio","year":"2012","unstructured":"Anast\u00e1cio, L. R. et al. Weight loss during cirrhosis is related to the etiology of liver disease. Arq. Gastroenterol. 49, 195\u2013198 (2012).","journal-title":"Arq. Gastroenterol."},{"key":"4571_CR41","doi-asserted-by":"publisher","unstructured":"Dooley, J., Lok, A., Garcia-Tsao, G. & Pinzani, M. Sherlock\u2019s Disease of the Liver and Biliary System (Wiley Blackwell, 2018). https:\/\/doi.org\/10.31826\/9781463236984-toc.","DOI":"10.31826\/9781463236984-toc"},{"key":"4571_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/wdev.340","volume":"8","author":"A Abu Rmilah","year":"2019","unstructured":"Abu Rmilah, A. et al. Understanding the marvels behind liver regeneration. Wiley Interdiscip Rev. Dev. Biol. 8, 1\u201346 (2019).","journal-title":"Wiley Interdiscip Rev. Dev. Biol."},{"key":"4571_CR43","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/1097-0215(20000901)87:5<629::AID-IJC2>3.0.CO;2-P","volume":"87","author":"DK Kim","year":"2000","unstructured":"Kim, D. K. et al. Apoptotic activity of ursolic acid May correlate with the Inhibition of initiation of DNA replication. Int. J. Cancer. 87, 629\u2013636 (2000).","journal-title":"Int. J. Cancer"},{"key":"4571_CR44","first-page":"413","volume":"58","author":"G Mittal","year":"2006","unstructured":"Mittal, G., Brar, A. P. S. & Soni, G. Impact of hypercholesterolemia on toxicity of N-nitrosodiethylamine: biochemical and histopathological effects. Pharmacol. Rep. 58, 413\u2013419 (2006).","journal-title":"Pharmacol. Rep."},{"key":"4571_CR45","doi-asserted-by":"publisher","unstructured":"Cattley, R. C. & Cullen, J. M. Liver and gall bladder. In Haschek and Rousseaux\u2019s Handbook of Toxicologic Pathologyhttps:\/\/doi.org\/10.1016\/B978-0-12-415759-0.00045-5  (2013).","DOI":"10.1016\/B978-0-12-415759-0.00045-5"},{"key":"4571_CR46","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/cmi.2016.3","volume":"13","author":"MW Robinson","year":"2016","unstructured":"Robinson, M. W., Harmon, C. & O\u2019Farrelly, C. Liver immunology and its role in inflammation and homeostasis. Cell. Mol. Immunol. 13, 267\u2013276 (2016).","journal-title":"Cell. Mol. Immunol."},{"key":"4571_CR47","first-page":"7029","volume":"34","author":"RMG Da Costa","year":"2014","unstructured":"Da Costa, R. M. G. et al. The N-Nitrosodiethylamine mouse model: sketching a timeline of evolution of Chemically-induced hepatic lesions. Anticancer Res. 34, 7029\u20137038 (2014).","journal-title":"Anticancer Res."},{"key":"4571_CR48","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.cbi.2006.03.007","volume":"161","author":"G Ramakrishnan","year":"2006","unstructured":"Ramakrishnan, G., Raghavendran, H. R. B., Vinodhkumar, R. & Devaki, T. Suppression of N-nitrosodiethylamine induced hepatocarcinogenesis by Silymarin in rats. Chem. Biol. Interact. 161, 104\u2013114 (2006).","journal-title":"Chem. Biol. Interact."},{"key":"4571_CR49","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jobaz.2016.07.002","volume":"76","author":"U Latief","year":"2016","unstructured":"Latief, U., Husain, H., Mukherjee, D. & Ahmad, R. Hepatoprotective efficacy of Gallic acid during Nitrosodiethylamine-induced liver inflammation in Wistar rats. J. Basic. Appl. Zool. 76, 31\u201341 (2016).","journal-title":"J. Basic. Appl. Zool."},{"key":"4571_CR50","unstructured":"Moriles, K. E. & Azer, S. A. Alanine amino transferase. StatPearls Publ. 2024, 1\u20137 (2024)."},{"key":"4571_CR51","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1503\/cmaj.1040752","volume":"172","author":"EG Giannini","year":"2005","unstructured":"Giannini, E. G., Testa, R. & Savarino, V. Liver enzyme alteration: a guide for clinicians. C Can. Med. Assoc. J. 172, 367\u2013379 (2005).","journal-title":"C Can. Med. Assoc. J."},{"key":"4571_CR52","first-page":"352","volume":"2","author":"AR Guerra Ruiz","year":"2021","unstructured":"Guerra Ruiz, A. R. et al. Measurement and clinical usefulness of bilirubin in liver disease. Adv. Lab. Med. 2, 352\u2013361 (2021).","journal-title":"Adv. Lab. Med."},{"key":"4571_CR53","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/ajg.2016.517","volume":"112","author":"PY Kwo","year":"2017","unstructured":"Kwo, P. Y., Cohen, S. M. & Lim, J. K. ACG clinical guideline: evaluation of abnormal liver chemistries. Am. J. Gastroenterol. 112, 18\u201335 (2017).","journal-title":"Am. J. Gastroenterol."},{"key":"4571_CR54","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/MOG.0000000000000167","volume":"31","author":"S Helmke","year":"2015","unstructured":"Helmke, S., Colmenero, J. & Everson, G. T. Noninvasive assessment of liver function. Curr. Opin. Gastroenterol. 31, 199\u2013208 (2015).","journal-title":"Curr. Opin. Gastroenterol."},{"key":"4571_CR55","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s12072-015-9665-6","volume":"10","author":"R Spinella","year":"2016","unstructured":"Spinella, R., Sawhney, R. & Jalan, R. Albumin in chronic liver disease: structure, functions and therapeutic implications. Hepatol. Int. 10, 124\u2013132 (2016).","journal-title":"Hepatol. Int."},{"key":"4571_CR56","doi-asserted-by":"crossref","unstructured":"Garcia-Martinez, R. et al. Albumin: Pathophysiologic basis of its role in the treatment of cirrhosis and its complications. Hepatology 58, 1836\u20131846 (2013).","DOI":"10.1002\/hep.26338"},{"key":"4571_CR57","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1258\/acb.2012.201217","volume":"49","author":"E Connell","year":"2012","unstructured":"Connell, E. Tietz textbook of clinical chemistry and molecular diagnostics. Ann. Clin. Biochem.: Int. J. Lab. Med. 49, 615\u2013615 (2012). 5th ed.","journal-title":"Ann. Clin. Biochem.: Int. J. Lab. Med."},{"key":"4571_CR58","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/j.1478-3231.2008.01716.x","volume":"28","author":"J Fevery","year":"2008","unstructured":"Fevery, J. Bilirubin in clinical practice: a review. Liver Int. 28, 592\u2013605 (2008).","journal-title":"Liver Int."},{"key":"4571_CR59","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1093\/clinchem\/46.12.2050","volume":"46","author":"DR Dufour","year":"2000","unstructured":"Dufour, D. R. et al. Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Clin. Chem. 46, 2050\u20132068 (2000).","journal-title":"Clin. Chem."},{"key":"4571_CR60","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/s41575-018-0045-2","volume":"15","author":"M Bernardi","year":"2018","unstructured":"Bernardi, M. & Caraceni, P. Novel perspectives in the management of decompensated cirrhosis. Nat. Rev. Gastroenterol. Hepatol. 15, 753\u2013764 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"4571_CR61","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/jpen.1451","volume":"43","author":"PB Soeters","year":"2019","unstructured":"Soeters, P. B., Wolfe, R. R. & Shenkin, A. Hypoalbuminemia: pathogenesis and clinical significance. J. Parenter. Enter. Nutr. 43, 181\u2013193 (2019).","journal-title":"J. Parenter. Enter. Nutr."},{"key":"4571_CR62","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1136\/gutjnl-2019-318843","volume":"69","author":"M Bernardi","year":"2020","unstructured":"Bernardi, M. et al. Albumin in decompensated cirrhosis: new concepts and perspectives. Gut 69, 1127\u20131138 (2020).","journal-title":"Gut"},{"key":"4571_CR63","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.jhep.2020.04.033","volume":"73","author":"H Han","year":"2020","unstructured":"Han, H. et al. Danger signals in liver injury and restoration of homeostasis. J. Hepatol. 73, 933\u2013951 (2020).","journal-title":"J. Hepatol."},{"key":"4571_CR64","doi-asserted-by":"crossref","unstructured":"Iweala, E. E. J., Evbakhavbokun, W. O. & Maduagwu, E. N. Antioxidant and hepatoprotective effect of Cajanus cajan in N-nitrosodiethylamine-induced liver damage. Sci. Pharm. 87, 456 (2019).","DOI":"10.3390\/scipharm87030024"},{"key":"4571_CR65","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jconrel.2004.07.033","volume":"100","author":"N Maeda","year":"2004","unstructured":"Maeda, N. et al. Anti-neovascular therapy by use of tumor neovasculature-targeted long-circulating liposome. J. Control Release. 100, 41\u201352 (2004).","journal-title":"J. Control Release"},{"key":"4571_CR66","doi-asserted-by":"publisher","first-page":"e3000411","DOI":"10.1371\/journal.pbio.3000411","volume":"18","author":"Percie du Sert","year":"2020","unstructured":"Percie du Sert. Reporting animal research: explanation and elaboration for the ARRIVE guidelines 2.0. PLOS Biol. 18, e3000411 (2020).","journal-title":"PLOS Biol."},{"key":"4571_CR67","first-page":"725","volume":"40","author":"G Schumann","year":"2002","unstructured":"Schumann, G. et al. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37\u00b0C. International federation of clinical chemistry and laboratory medicine. Part 5. Reference procedure for the measurement of catalytic concentrat. Clin. Chem. Lab. Med. 40, 725\u2013733 (2002).","journal-title":"Clin. Chem. Lab. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04571-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04571-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04571-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T18:02:09Z","timestamp":1748800929000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04571-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,1]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4571"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-04571-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,1]]},"assertion":[{"value":"3 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The animal experiments in this study complied with the protocol approved by the Ethical Committee of the Faculty of Veterinary Medicine, Universitas Airlangga, Indonesia, through ethical clearance vide certificate number 2.KEH.035.04.2022, dated April 1, 2022. All methods were performed in accordance with ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"19225"}}